Who owns Igm Biosciences Inc Com?
- Ticker: IGMS
- CUSIP Number: 449585108
Tip: Access positions for across all investors
Analyze quarterly positions in Igm Biosciences with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Igm Biosciences stock
Who bought or sold Igm Biosciences Inc Com this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Baker Bros. Advisors | 4.1M | $40M | 11% | Mar 2024 |
|
| T. Rowe Price Associates | 3.9M | $38M | 19% | Mar 2024 |
|
| Artal Group | 3.1M | $30M | -1% | Mar 2024 |
|
| Redmile Group | 3.1M | $30M | 3% | Mar 2024 |
|
| FMR | 1.3M | $13M | -38% | Mar 2024 |
|
| Goldman Sachs Group | 1.3M | $12M | 23% | Mar 2024 |
|
| RA Capital Management | 938k | $9.0M | 0% | Mar 2024 |
|
| Vanguard Group | 854k | $8.2M | -5% | Mar 2024 |
|
| BlackRock | 758k | $7.3M | -13% | Mar 2024 |
|
| Millennium Management | 695k | $6.7M | 181% | Mar 2024 |
|
| Geode Capital Management | 336k | $3.2M | 15% | Mar 2024 |
|
| Rhenman & Partners Asset Management AB | 195k | $1.9M | -2% | Mar 2024 |
|
| TD Asset Management | 159k | $1.5M | 91% | Mar 2024 |
|
| Samsara BioCapital | 155k | $1.5M | 0% | Mar 2024 |
|
| Northern Trust | 137k | $1.3M | 1% | Mar 2024 |
|
| Charles Schwab Investment Management | 121k | $1.2M | 0% | Mar 2024 |
|
| Morgan Stanley | 101k | $976k | 37% | Mar 2024 |
|
| D. E. Shaw & Co | 93k | $899k | 97% | Mar 2024 |
|
| Jacobs Levy Equity Management | 79k | $758k | 100% | Mar 2024 |
|
| Woodline Partners | 75k | $724k | 0% | Mar 2024 |
|
| Marshall Wace | 71k | $683k | 100% | Mar 2024 |
|
| Bruce & Co | 65k | $627k | 0% | Mar 2024 |
|
| Pennant Investors | 65k | $626k | 100% | Mar 2024 |
|
| Bank of New York Mellon | 50k | $478k | -5% | Mar 2024 |
|
| Eagle Bay Advisors | 45k | $431k | 0% | Mar 2024 |
|
| Nuveen Asset Management | 41k | $393k | -49% | Mar 2024 |
|
| Dimensional Fund Advisors | 40k | $381k | 0% | Mar 2024 |
|
| Alliancebernstein | 32k | $268k | -9% | Dec 2023 |
|
| Jane Street | 31k | $300k | -13% | Mar 2024 |
|
| Susquehanna Portfolio Strategies | 30k | $292k | 100% | Mar 2024 |
|
| Citadel Advisors | 28k | $273k | -88% | Mar 2024 |
|
| Exchange Traded Concepts | 28k | $270k | 47% | Mar 2024 |
|
| Susquehanna Fundamental Investments | 28k | $268k | 100% | Mar 2024 |
|
| PanAgora Asset Management | 23k | $225k | -23% | Mar 2024 |
|
| Bank of America Corporation | 22k | $215k | -10% | Mar 2024 |
|
| Walleye Trading Advisors | 21k | $204k | 100% | Mar 2024 |
|
| ExodusPoint Capital Management | 20k | $196k | -96% | Mar 2024 |
|
| Rhumbline Advisers | 20k | $194k | 5% | Mar 2024 |
|
| Barclays | 19k | $184k | -22% | Mar 2024 |
|
| GSA Capital Partners | 18k | $178k | 100% | Mar 2024 |
|
| Two Sigma Investments | 17k | $167k | 100% | Mar 2024 |
|
| American Century Companies | 17k | $165k | 100% | Mar 2024 |
|
| Virtus ETF Advisers | 13k | $129k | -6% | Mar 2024 |
|
| UBS Group | 13k | $129k | 1% | Mar 2024 |
|
| XTX Topco | 12k | $115k | 4% | Mar 2024 |
|
| Brevan Howard Capital Management | 11k | $102k | -11% | Mar 2024 |
|
| HPM Partners | 11k | $102k | 100% | Mar 2024 |
|
| Captrust Financial Advisors | 10k | $98k | 100% | Mar 2024 |
|
| Quest Partners | 7.0k | $67k | 100% | Mar 2024 |
|
| American International | 6.6k | $55k | 11% | Dec 2023 |
|
| New York State Common Retirement Fund | 6.5k | $63k | 0% | Mar 2024 |
|
| Jpmorgan Chase & Co | 5.8k | $56k | -40% | Mar 2024 |
|
| Deutsche Bank Aktiengesellschaft | 5.5k | $54k | -53% | Mar 2024 |
|
| Wells Fargo & Company | 4.8k | $47k | 14% | Mar 2024 |
|
| ADAR1 Capital Management | 4.0k | $39k | 100% | Mar 2024 |
|
| NISA Investment Advisors | 3.9k | $38k | 0% | Mar 2024 |
|
| Citigroup | 2.5k | $24k | 34% | Mar 2024 |
|
| nVerses Capital | 1.6k | $15k | 100% | Mar 2024 |
|
| California State Teachers Retirement System | 1.3k | $13k | -91% | Mar 2024 |
|
| Summit Investment Advisors | 1.3k | $13k | 112% | Mar 2024 |
|
| Legal & General Group | 1.0k | $9.8k | -36% | Mar 2024 |
|
| Quantbot Technologies | 800.00 | $7.7k | -56% | Mar 2024 |
|
| Brian McDonald | 617.00 | $6.0k | 100% | Mar 2024 |
|
| Amalgamated Bank | 351.00 | $3.0k | -65% | Mar 2024 |
|
| Royal Bank of Canada | 302.00 | $0 | -95% | Mar 2024 |
|
| Tower Research Capital | 258.00 | $2.5k | -91% | Mar 2024 |
|
| Signature | 187.00 | $1.8k | 523% | Mar 2024 |
|
| Nbc Securities | 150.00 | $1.0k | 0% | Mar 2024 |
|
| GAMMA Investing | 76.00 | $732.997200 | 100% | Mar 2024 |
|
| Russell Investments | 75.00 | $723.997500 | 0% | Mar 2024 |
|
| Us Bancorp | 17.00 | $164.000700 | 0% | Mar 2024 |
|
| Farther Finance Advisors | 9.00 | $84.999600 | 0% | Mar 2024 |
|
| Pnc Financial Services | 7.00 | $68.000100 | 0% | Mar 2024 |
|
| Group One Trading | 4.00 | $39.000000 | -98% | Mar 2024 |
|
| Nelson, Van Denburg & Campbell Wealth Management | 3.00 | $27.999900 | 100% | Mar 2024 |
|
| CWM | 1.00 | $0 | 100% | Mar 2024 |
|
Who sold out of Igm Biosciences?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| First Manhattan | Sep 2023 | 172k | $1.4M |
| Exome Asset Management | Dec 2023 | 136k | $1.1M |
| Hudson Bay Capital Management | Dec 2023 | 124k | $1.0M |
| Springbok Capital Management | Sep 2023 | 37k | $311k |
| State of Wisconsin Investment Board | Dec 2023 | 30k | $246k |
| Amundi | Dec 2023 | 9.2k | $107k |
| Lazard Asset Management | Sep 2023 | 6.3k | $52k |
| Simplex Trading | Dec 2023 | 1.8k | $15k |
| Qube Research & Technologies | Sep 2023 | 936.00 | $7.8k |